Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA
Go back to Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA| Omeros Corporation (NASDAQ: OMER) | Delayed: 19.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.12 | 52 Week High | $16.80 | |||
| Open | $19.12 | 52 Week Low | $7.20 | |||
| Day High | $19.12 | P/E | N/A | |||
| Day Low | $19.12 | EPS | $-1.64 | |||
| Volume | 679 | |||||
